Back to search
FDAFDA · Food and drugs·Recall number D-0471-2017

Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3.

Published February 15, 2017 · Recall initiated: December 19, 2016

Summary

FDA records drug Class III recall D-0471-2017, published February 15, 2017 and initiated December 19, 2016. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 67,946 bottles; Lot: Lot #: MJ7746, Exp 04/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: Product may not meet specifications throughout shelf life.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide in the USA
Lot
Lot #: MJ7746, Exp 04/17
Risk classification
Class III
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9; Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-3075-3. recalled?

Yes. FDA published recall D-0471-2017 on February 15, 2017. Reported hazard: Superpotent Drug: Product may not meet specifications throughout shelf life.

What should I do if I have this product?

Voluntary: Firm initiated · Letter